Psychobiology and treatment of borderline personality disorder

被引:10
|
作者
Cloninger, CR [1 ]
机构
[1] Washington Univ, Sch Med, Dept Psychiat, St Louis, MO 63110 USA
来源
ACTA NEUROPSYCHIATRICA | 2002年 / 14卷 / 02期
关键词
borderline; biology; genetics; impulsivity;
D O I
10.1034/j.1601-5215.2002.140202.x
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Borderline personality disorder can be characterized in terms of a profile of abnormal deviations on multiple personality dimensions using the temperament and character inventory (M). Borderline patients show poor character development, including low TCI self-directedness (irresponsible, blaming) and low TCI cooperativeness (hostile, intolerant). Their temperament is explosive or unstable due to a combination of high TCI harm avoidance (anxious, shy), high TCI novelty seeking (impulsive, quick-tempered), and low reward dependence (cold, aloof). Consequently they are usually dysthymic with an admixture of anxiety and anger, and regulate their social problems and intense emotions in immature ways. Genetic and psychobiological studies have led to identification of biological correlates of each of the TCI dimensions of personality, including individual differences in regional brain activity, psychophysiological variables, neuroendocrine abnormalities and specific gene polymorphisms. Each dimension of personality involves complex non-linear interaction of multiple genetic and environmental factors and, in turn, each personality dimension interacts with the others in influencing the way an individual directs and adapts to his or her life experiences. Systematic clinical trials have shown that these personality variables predict the response to pharmacological and psychotherapeutic treatments. For example, high harm avoidance and low self-directedness predict slower response and more rapid relapse with both antidepressants and cognitive-behavioral therapy. Treatment with drugs and/or psychotherapy can be individually matched to the patient's profile of temperament and character traits, rather than treating a heterogeneous group of patients as if they had a discrete, homogeneous illness. Fundamental change in cognitive schemas depends on attention to all aspects of character, especially self-transcendence, which has previously been neglected in cognitive-behavioral therapy. Personality integration requires nonresistance to our natural intuitive awareness, rather than intensified intellectual and emotional defenses.
引用
收藏
页码:60 / 65
页数:6
相关论文
共 50 条
  • [1] Treatment of Borderline Personality Disorder
    Levy, Kenneth N.
    McMain, Shelley
    Bateman, Anthony
    Clouthier, Tracy
    PSYCHIATRIC CLINICS OF NORTH AMERICA, 2018, 41 (04) : 711 - +
  • [2] Treatment of borderline personality disorder
    Mountain, D
    BRITISH JOURNAL OF PSYCHIATRY, 2006, 188 : 493 - 493
  • [3] The treatment of borderline personality disorder
    Eckert, J
    Dulz, B
    Makowski, C
    PSYCHOTHERAPEUT, 2000, 45 (05): : 271 - 285
  • [4] Treatment of borderline personality disorder
    Shapiro, ER
    Plakun, EM
    AMERICAN JOURNAL OF PSYCHIATRY, 1998, 155 (11): : 1645 - 1646
  • [5] Borderline Personality Disorder Barriers to Borderline Personality Disorder Treatment and Opportunities for Advocacy
    Tusiani-Eng, Paula
    Yeomans, Frank
    PSYCHIATRIC CLINICS OF NORTH AMERICA, 2018, 41 (04) : 695 - +
  • [6] Treatment Advances in Borderline Personality Disorder
    Nelson, Katharine J.
    Schulz, S. Charles
    PSYCHIATRIC ANNALS, 2012, 42 (02) : 59 - 64
  • [7] Treatment and prevention of borderline personality disorder
    Taubner, Svenja
    PSYCHOTHERAPEUT, 2020, 65 (05): : 329 - 330
  • [8] Quetiapine in the treatment of borderline personality disorder
    Hilger, E
    Barnas, C
    Kasper, S
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2002, 12 : S329 - S329
  • [9] Venlafaxine in the treatment of borderline personality disorder
    Markovitz, PJ
    Wagner, SC
    PSYCHOPHARMACOLOGY BULLETIN, 1995, 31 (04) : 773 - 777
  • [10] Fluoxetine in the treatment of borderline personality disorder
    Silva, H
    Jerez, S
    Paredes, A
    Salvo, J
    Renteria, P
    Ramirez, A
    Montes, C
    ACTAS LUSO-ESPANOLAS DE NEUROLOGIA PSIQUIATRIA Y CIENCIAS AFINES, 1997, 25 (06): : 391 - 395